{"DataElement":{"publicId":"7449894","version":"1","preferredName":"Total Normal Tissue Segment Comment Text","preferredDefinition":"A free text field to provide additional information regarding the entire non-neoplastic (\"normal\") adjacent tissue specimen that was divided into segments for proteomic and genomic analysis.","longName":"7449878v1.0:6847557v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7449878","version":"1","preferredName":"Total Normal Tissue Segment Comment","preferredDefinition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._Sufficient total material from each patient, divided to yield a minimum of one aliquot, preferably divided into one to three aliquots of non-neoplastic (\"normal\") adjacent tissue (as feasible) suitable for processing for proteomic and genomic analysis._A written explanation, observation or criticism added to textual material.","longName":"7449862v1.0:2223274v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7449862","version":"1","preferredName":"Total Normal Tissue Segment","preferredDefinition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.:Sufficient total material from each patient, divided to yield a minimum of one aliquot, preferably divided into one to three aliquots of non-neoplastic (\"normal\") adjacent tissue (as feasible) suitable for processing for proteomic and genomic analysis.","longName":"C25304:C162623","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Total","conceptCode":"C25304","definition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Normal Tissue Sample","conceptCode":"C162623","definition":"Tissue sample with cellular composition and architectural patterns expected for the particular anatomic site in which it belongs. There is no evidence of abnormal cellular infiltrates or tumor mass formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B0A011F8-0650-3694-E053-4EBD850A4D8A","latestVersionIndicator":"Yes","beginDate":"2020-10-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-10-01","modifiedBy":"ONEDATA","dateModified":"2020-10-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2223274","version":"1","preferredName":"Comment","preferredDefinition":"A written explanation or criticism or illustration that is added to a book or other textual material.","longName":"C25393","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Comment","conceptCode":"C25393","definition":"A written explanation, observation or criticism added to textual material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F629FF0E-4B75-2183-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B09FB49A-58D7-3692-E053-4EBD850A0EE6","latestVersionIndicator":"Yes","beginDate":"2020-10-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-10-01","modifiedBy":"KNABLEJ","dateModified":"2021-02-12","changeDescription":"2/12/21 jk Released per SME (NGM) review and approval.10/1/20 jk created for Solid Tumor Procurement CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6847557","version":"1","preferredName":"4000 Character Text","preferredDefinition":"The words of something written.","longName":"6847557v1.0","context":"OCCPR","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"4000","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8F78F00C-3668-5BB9-E053-F662850A122E","latestVersionIndicator":"Yes","beginDate":"2019-08-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-08-06","modifiedBy":"KNABLEJ","dateModified":"2020-02-12","changeDescription":"1/2/20 jk Released per CPTAC SME (Linda) for PRAD Baseline CRF.  8/6/19 jk created for multiple CPTAC CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"7409064","version":"1","longName":"All Procurement CRFs","context":"OCCPR"},{"publicId":"7409065","version":"1","longName":"Solid Tumor Specimen","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Comments","type":"Preferred Question Text","description":"Comments","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B0A16C8E-EFB3-30BC-E053-4EBD850A595B","latestVersionIndicator":"Yes","beginDate":"2020-10-01","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-10-01","modifiedBy":"KNABLEJ","dateModified":"2021-02-12","changeDescription":"2/12/21 jk  upd def per SME comment; upd Reg Status and released.  12/15/20 jk Removed Normal Tissue CSI; new CDE per SME for CRF.10/30/20 jk added Normal Tissue CSI. 10/1/20 jk created CPTAC Solid tumor procurement CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}